Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-07-31
1997-09-02
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3120
Patent
active
056632029
ABSTRACT:
Damage to the gastrointestinal tract as a consequence of exposure to ionising radiation is prevented or treated by administration of GLA and/or DGLA. Medicaments containing GLA and/or DGLA for such treatment or prevention may also further comprise EPA and/or DHA.
REFERENCES:
patent: 4996233 (1991-02-01), Horrobin
patent: 4997649 (1991-03-01), Papaconstantin et al.
patent: 5059622 (1991-10-01), Sears
patent: 5271925 (1993-12-01), Sredni et al.
Database WPI Week 9111, Derwent AN 91-075338 (Mar. 1991).
Database WPI Week 8951 Derwent AN 89-372299 (Dec. 1989).
British Journal of Cancer vol. 68, No. 1, (Jul. 1993) pp. 1-7 Hopewell et al "The Modulation of Radiation-induced Damage to Pig Skin by Essential Fatt Acids".
Nutrition Research vol. 5, (1985) pp. 101-105 Das et al "Benzo(a)pyrene and Gamma-Radiation-Induced . . . ".
Prostaglandins, vol. 29, No. 6, (Jun. 1985) pp. 911-920 "Prostaglandins and their Precursors Can Modify Genetic Damage Induced by Gamma-Radiation and Benzo(a)pyrene".
Horrobin David F.
Scott Catherine A.
Henley III Raymond
Soctia Holdings PLC
LandOfFree
Treatment for internal radiation damage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment for internal radiation damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for internal radiation damage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-308676